Stock ODX CAMBRIDGE NUTRITIONAL SCIENCES PLC
Add to a list
To use this feature you must be a member
Log inSign up

Cambridge Nutritional Sciences plc Stock

Equities

ODX

GB00B1VCP282

Medical Equipment, Supplies & Distribution

Market Closed - London S.E.
Other stock markets
 11:35:02 2024-05-03 am EDT 		5-day change 1st Jan Change
3.95 GBX 0.00% Intraday chart for Cambridge Nutritional Sciences plc +2.60% +64.58%
Apr. 22 Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named MT
Apr. 22 Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024 CI
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 9M 11.29M Sales 2025 * - Capitalization 9.4M 11.79M
Net income 2024 * -1M -1.25M Net income 2025 * - EV / Sales 2024 * 0.58 x
Net cash position 2024 * 4.2M 5.27M Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-7.9 x
P/E ratio 2025 *
-
Employees 91
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.83%
More Fundamentals * Assessed data

Chart Cambridge Nutritional Sciences plc

Dynamic Chart

Latest news about Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named MT
Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024 CI
Cambridge Nutritional Sciences plc Announces Board Changes CI
Cambridge Nutritional Sciences hires first operations chief AN
Cambridge Nutritional Sciences plc Announces Appointment of James Cooper as Operations Director CI
Cambridge Nutritional Sciences develops education programme AN
Transcript : Cambridge Nutritional Sciences plc, H1 2024 Earnings Call, Nov 23, 2023
Cambridge Nutrition loss narrows as revenue surges; outlook optimistic AN
Earnings Flash (CNSL.L) CAMBRIDGE NUTRITIONAL SCIENCES Reports H1 Revenue GBP4.9M MT
Earnings Flash (CNSL.L) CAMBRIDGE NUTRITIONAL SCIENCES Reports Fiscal H1 Loss GBX-0.30 MT
Cambridge Nutritional Sciences plc Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Cambridge Nutritional Sciences plc Provides Revenue Guidance for the Fiscal Year 2024 CI
Cambridge Nutritional Sciences completes name change AN
Omega Diagnostics Group Officially Changes Name to Cambridge Nutritional Sciences MT
Omega Diagnostics Group PLC has Changed its Name to Cambridge Nutritional Sciences plc CI
More news

Latest transcript on Cambridge Nutritional Sciences plc

Logo Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc, H1 2024 Earnings Call, Nov 23, 2023
More transcripts

Analyst Recommendations on Cambridge Nutritional Sciences plc

FTSE Seen Sharply Lower on Risk of Emergency Fed Rate Rise DJ
More recommendations

Press releases Cambridge Nutritional Sciences plc

Omega Diagnostics : COVIS-19 ELISA - Approval for sale in India PU
Omega Diagnostics : Fundraising to raise gross proceeds of up to £11m PU
Omega Diagnostics : Material Transfer Agreement with Mologic on COVID-19 PU
Omega Diagnostics : Interim Results - Year Ended 30 September 2019 PU
Omega Diagnostics : Investor Briefing PU
More press releases

Quotes and Performance

1 week+2.60%
Current month+1.28%
1 month+16.18%
3 months+38.60%
6 months+79.55%
Current year+64.58%
More quotes

Highs and lows

1 week
3.70
Extreme 3.7
4.08
1 month
3.20
Extreme 3.2
4.17
Current year
2.30
Extreme 2.3
4.17
1 year
1.66
Extreme 1.662
4.17
3 years
1.66
Extreme 1.662
88.80
5 years
1.66
Extreme 1.662
126.95
10 years
1.66
Extreme 1.662
126.95
More quotes

Managers and Directors - Cambridge Nutritional Sciences plc

Managers TitleAgeSince
Jag Grewal CEO
 Chief Executive Officer 54 11-06-29
Members of the board TitleAgeSince
Jag Grewal CEO
 Chief Executive Officer 54 11-06-29
Jeremy Millard BRD
 Director/Board Member 53 19-02-28
Carolyn Rand CHM
 Chairman 60 23-08-16
More insiders

Quotes

Date Price Change Volume
24-05-03 3.95 0.00% 127,670
24-05-02 3.95 0.00% 167,297
24-05-01 3.95 +1.28% 137,118
24-04-30 3.9 -1.27% 162,099
24-04-29 3.95 +2.60% 1,178,848

Delayed Quote London S.E., May 03, 2024 at 11:35 am EDT

More quotes

Company Profile

Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-06-05 - Integrative and Personalised Medicine Conference
More about the company

Income Statement Evolution

More financial data

Ratings for Cambridge Nutritional Sciences plc

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
CAMBRIDGE NUTRITIONAL SCIENCES PLC Stock Cambridge Nutritional Sciences plc
+64.58% 11.8M
BIOMÉRIEUX Stock bioMérieux
-1.89% 12.56B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.68B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
-1.31% 5.29B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+21.82% 5.24B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.57B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.89% 3.29B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.6B
VITROLIFE AB Stock Vitrolife AB
-10.02% 2.2B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.29% 1.79B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. ODX Stock